| 12455131 |
Techniques for indicating gun state information |
Kai Thorin Kloepfer, Benjamin William Dwyer, Donna Kelley, Jack Hugo Thiesen, Christopher James Owens |
2025-10-28 |
|
| 12442609 |
Systems for managing an energy store at a gun |
Benjamin William Dwyer, Samuel James Farmer, Sara Elizabeth Falcone |
2025-10-14 |
|
| 12415796 |
Inhibitors of (αv)(β6) integrin |
Mark Brewer, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Bryce A. Harrison +6 more |
2025-09-16 |
|
| 12221416 |
Antagonists of human integrin α4β7 |
Matthew G. Bursavich, Dawn M. Troast, Bryce A. Harrison, Blaise S. Lippa, Kyle D. Konze +9 more |
2025-02-11 |
|
| 12145935 |
Inhibitors of (α-v)(β-6) integrin |
Bryce A. Harrison, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Kyle D. Konze +5 more |
2024-11-19 |
|
| 11964961 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2024-04-23 |
$398,665,000 |
| 11827621 |
Inhibitors of (α-v)(β-6) integrin |
Mark Brewer, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Bryce A. Harrison +6 more |
2023-11-28 |
|
| 11795167 |
Inhibitors of (α-v)(β-6) integrin |
Bryce A. Harrison, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Kyle D. Konze +5 more |
2023-10-24 |
|
| 11739087 |
Inhibiting (α-v)(β-6) integrin |
Bryce A. Harrison, James E. Dowling, Matthew G. Bursavich, Dawn M. Troast, Blaise S. Lippa +12 more |
2023-08-29 |
|
| 11370773 |
Inhibiting human integrin (alpha-4) (beta-7) |
Matthew G. Bursavich, Dan Cui, James E. Dowling, Kristopher N. Hahn, Bryce A. Harrison +12 more |
2022-06-28 |
|
| 11174228 |
Antagonists of human integrin (α4)(β7) |
Matthew G. Bursavich, Dawn M. Troast, Bryce A. Harrison, Blaise S. Lippa, Kyle D. Konze +9 more |
2021-11-16 |
|
| 11104661 |
Inhibiting human integrin (α-4) (β-7) |
Matthew G. Bursavich, Dan Cui, James E. Dowling, Kristopher N. Hahn, Bryce A. Harrison +12 more |
2021-08-31 |
|
| 11046669 |
Inhibitors of (α-v)(β-6) integrin |
Bryce A. Harrison, Matthew G. Bursavich, Mark Brewer, Aleksey I. Gerasyuto, Kristopher N. Hahn +6 more |
2021-06-29 |
|
| 11046685 |
Inhibitors of (α-v)(β-6) integrin |
Bryce A. Harrison, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Kyle D. Konze +5 more |
2021-06-29 |
|
| 11040955 |
Inhibitors of (alpha-v)(beta-6) integrin |
Mark Brewer, Matthew G. Bursavich, Aleksey I. Gerasyuto, Kristopher N. Hahn, Bryce A. Harrison +6 more |
2021-06-22 |
|
| 11021480 |
Inhibiting (α-V)(β-6) integrin |
Bryce A. Harrison, James E. Dowling, Matthew G. Bursavich, Dawn M. Troast, Blaise S. Lippa +6 more |
2021-06-01 |
|
| 11014909 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2021-05-25 |
$425,301,000 |
| 10759756 |
Antagonists of human integrin α4β7 |
Matthew G. Bursavich, Dawn M. Troast, Bryce A. Harrison, Blaise S. Lippa, Kyle D. Konze +9 more |
2020-09-01 |
|
| 10723711 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert +6 more |
2020-07-28 |
$482,302,000 |
| 10696658 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2020-06-30 |
$597,435,000 |
| 10428034 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors |
Christopher Ryan Butler, Laura Ann McAllister, Elizabeth Mary Beck, Michael Aaron Brodney, Adam Matthew Gilbert +6 more |
2019-10-01 |
$298,967,000 |
| 10421744 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2019-09-24 |
$287,330,000 |
| 10316021 |
Heteroarylphenoxy benzamide kappa opioid ligands |
Natasha Mariam Kablaoui, Michael Eric Green, Justin Ian Montgomery, Michael Aaron Brodney, Patrick Robert Verhoest +5 more |
2019-06-11 |
$297,650,000 |
| 10093655 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
Michael Aaron Brodney, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov, David Lawrence Firman Gray +6 more |
2018-10-09 |
$408,783,000 |
| 10077272 |
Heteroaromatic compounds and their use as dopamine D1 ligands |
David Lawrence Firman Gray, Lei Zhang, Jennifer Elizabeth Davoren, Amy Beth Dounay, Ivan Viktorovich Efremov +4 more |
2018-09-18 |
$396,134,000 |
